These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2480 related articles for article (PubMed ID: 21848624)

  • 1. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
    Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
    Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIT gene exon 11 mutations in canine malignant melanoma.
    Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
    Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-kit expression in canine mucosal melanomas.
    Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF and c-kit gene copy number in mutation-positive malignant melanoma.
    Willmore-Payne C; Holden JA; Hirschowitz S; Layfield LJ
    Hum Pathol; 2006 May; 37(5):520-7. PubMed ID: 16647948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
    Han JI; Kim Y; Kim DY; Na KJ
    Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
    Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
    Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-kit gene mutation and CD117 expression in human anorectal melanomas.
    Ni S; Huang D; Chen X; Huang J; Kong Y; Xu Y; Du X; Sheng W
    Hum Pathol; 2012 Jun; 43(6):801-7. PubMed ID: 22154054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.
    Zavodovskaya R; Liao AT; Jones CL; Yip B; Chien MB; Moore PF; London CA
    Am J Vet Res; 2006 Apr; 67(4):633-41. PubMed ID: 16579756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between KIT Expression and
    Smedley RC; Thaiwong T; Deeth LE; Kiupel M
    Vet Pathol; 2021 Jul; 58(4):683-691. PubMed ID: 33910439
    [No Abstract]   [Full Text] [Related]  

  • 14. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
    Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
    Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?
    Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Martini V; Comazzi S; Dacasto M
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):325-32. PubMed ID: 23375718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
    Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
    Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 124.